LUCIANO, NICOLETTA
 Distribuzione geografica
Continente #
AS - Asia 1.000
NA - Nord America 888
EU - Europa 225
SA - Sud America 162
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 17
Totale 2.353
Nazione #
US - Stati Uniti d'America 838
SG - Singapore 597
CN - Cina 207
BR - Brasile 132
VN - Vietnam 88
IT - Italia 65
HK - Hong Kong 37
FR - Francia 36
DE - Germania 24
CA - Canada 22
MX - Messico 17
GB - Regno Unito 15
IN - India 12
PL - Polonia 12
AR - Argentina 11
FI - Finlandia 11
RU - Federazione Russa 10
SE - Svezia 9
BD - Bangladesh 8
ES - Italia 8
GR - Grecia 8
ZA - Sudafrica 7
JP - Giappone 6
AT - Austria 5
IQ - Iraq 5
NL - Olanda 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
ID - Indonesia 4
CR - Costa Rica 3
IE - Irlanda 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
GT - Guatemala 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PH - Filippine 2
TN - Tunisia 2
TR - Turchia 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
TC - Turks e Caicos 1
TG - Togo 1
UA - Ucraina 1
Totale 2.292
Città #
Singapore 272
San Jose 155
Ashburn 152
The Dalles 88
Council Bluffs 55
Beijing 51
Dallas 49
Shanghai 46
Hong Kong 36
Ho Chi Minh City 33
Santa Clara 28
Chandler 22
Milan 22
Los Angeles 20
New York 20
Hanoi 18
São Paulo 15
Warsaw 12
Helsinki 11
Mexico City 10
Rome 9
Phoenix 8
Stockholm 8
Da Nang 7
Buffalo 6
Frankfurt am Main 6
Montreal 6
Naples 6
Amsterdam 5
Boardman 5
Chicago 5
Düsseldorf 5
Paris 5
Rio de Janeiro 5
Springfield 5
Tashkent 5
Tokyo 5
Assago 4
Brooklyn 4
Haiphong 4
Lauterbourg 4
London 4
Brasília 3
Cape Town 3
Changsha 3
Chennai 3
Dublin 3
Falkenstein 3
Figino 3
Guarulhos 3
Hangzhou 3
Nairobi 3
Portsmouth 3
Qingdao 3
Queens 3
San Francisco 3
Seattle 3
São Bernardo do Campo 3
Thái Bình 3
Americana 2
Aparecida de Goiânia 2
Asheboro 2
Asunción 2
Atlanta 2
Baku 2
Boston 2
Brownsville 2
Calgary 2
Campo Grande 2
Cincinnati 2
Curitiba 2
Denver 2
Dhaka 2
Diadema 2
Dubai 2
Duque de Caxias 2
Ellicott City 2
Florence 2
Fort Worth 2
Georgetown 2
Guatapará 2
Guatemala City 2
Houston 2
Hải Dương 2
Isidro Casanova 2
Johannesburg 2
Jundiaí 2
Laval 2
Lima 2
Manchester 2
Ninh Bình 2
Nuremberg 2
Orlando 2
Perm 2
Philadelphia 2
Riverside 2
Riyadh 2
Salvador 2
Sassari 2
Stone Mountain 2
Totale 1.369
Nome #
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 110
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 94
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 91
A clinical prediction rule for lymphoma development in primary Sjögren's syndrome 79
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 69
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender 69
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 68
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 66
Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome 66
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review 63
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study 63
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 62
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 59
Myositis in primary Sjögren's syndrome: data from a multicentre cohort 59
The need to ask for directions on the winding road of psoriatic arthritis 58
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study 55
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 54
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 54
Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma 53
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study 53
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 51
Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes? 50
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 46
Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature 46
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study 46
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 46
Imaging in primary Sjögren's syndrome: the 'obsolete and the new' 45
Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases 45
Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study 44
Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome 44
One year in review 2015: Sjögren's syndrome 44
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 43
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 42
Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: Consensual US-SG core items definition and reliability 42
Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis 42
High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease 39
One year in review 2017: novelties in the treatment of rheumatoid arthritis 38
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience 38
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome 37
Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjögren's syndrome (pSS) clinical trials? 35
One year in review 2018: novelties in the treatment of rheumatoid arthritis 35
Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritis 32
Salivary Gland Ultrasonography in Sjögren's Syndrome: Clinical Usefulness and Future Perspectives 30
Natural language processing to intercept rheumatoid and psoriatic arthritis from clinical notes in the Emergency Department 16
Clinical phenotypes and therapeutic outcomes in enteropathic arthritis: a multivariate analysis from a retrospective cohort 16
Development of a confidence-based Natural Language Processing tool to identify inflammatory arthritis from non-inflammatory conditions in Rheumatology medical notes 8
Modulation of proinflammatory but not regulatory cytokines by in vitro JAK inhibition in peripheral blood B-cells of patients with psoriatic arthritis 8
Totale 2.353
Categoria #
all - tutte 12.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202352 0 2 4 9 3 6 0 10 11 4 1 2
2023/202435 5 1 6 2 1 7 2 2 0 3 1 5
2024/2025685 35 72 15 16 11 77 45 25 97 139 86 67
2025/20261.422 170 95 73 85 96 77 343 65 87 99 128 104
2026/2027159 58 101 0 0 0 0 0 0 0 0 0 0
Totale 2.353